Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort

被引：1
|
作者：
Rullan, M. [1 ]
Elosua, A. [1 ]
Saldana, C. [1 ]
Amorena, E. [1 ]
Vicuna, M. [1 ]
Rubio, S. [1 ]
Nantes, O. [1 ]
Rodriguez, C. [1 ]
机构：
[1] Complejo Hosp Navarra, Gastroenterol & Hepatol, Pamplona, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.792
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P668
引用
收藏
页码：S453 / S454
页数：2
相关论文
共 50 条
  • [1] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Sanchez Rodriguez, E.
    Mesonero Gismero, F.
    Lopez Sanroman, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S590 - S591
  • [2] Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy
    Scribano, Maria Lia
    Aratari, Annalisa
    Neri, Benedetto
    Bezzio, Cristina
    Balestrieri, Paola
    Baccolini, Valentina
    Falasco, Giuliano
    Camastra, Caterina
    Pantanella, Paolo
    Monterubbianesi, Rita
    Tullio, Alessandro
    Saibeni, Simone
    Papi, Claudio
    Biancone, Livia
    Cosintino, Rocco
    Faggiani, Roberto
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [3] Effectiveness of ustekinumab in refractory Crohn's disease: A real-life experience in a tertiary referral centre
    Truyens, M.
    Geldof, J.
    Dewitte, G.
    Glorieus, E.
    Hindryckx, P.
    Ortega, T. Lobaton
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S330 - S330
  • [4] Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland
    Eberl, A.
    Hallinen, T.
    af Bjorkesten, C. -G.
    Heikkinen, M.
    Hirsi, E.
    Kellokumpu, M.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nuutinen, H.
    Suhonen, U. -M.
    Utriainen, K.
    Vihriala, I.
    Soini, E.
    Wennerstrom, C.
    Nissinen, R.
    Borsi, A.
    Koivunen, M.
    Tillonen, J.
    Sipponen, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S415 - S416
  • [5] Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
    Eberl, Anja
    Hallinen, Taru
    af Bjorkesten, Clas-Goran
    Heikkinen, Markku
    Hirsi, Eija
    Kellokumpu, Mikko
    Koskinen, Inka
    Moilanen, Veikko
    Nielsen, Christian
    Nuutinen, Heikki
    Suhonen, Ulla-Maija
    Utriainen, Karri
    Vihriala, Ilkka
    Soini, Erkki
    Wennerstrom, Christina
    Nissinen, Riikka
    Borsi, Andras
    Koivunen, Minni
    Tillonen, Jyrki
    Sipponen, Taina
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 718 - 725
  • [6] Ustekinumab Use in Crohn's Disease: Real-Life Canadian Experience
    Greenup, Astrid-Jane
    Rosenfeld, Greg
    Bressler, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S334 - S335
  • [7] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mazzuoli, S.
    Manguso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Minerba, L.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
  • [8] COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN'S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mancuso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 : S140 - S141
  • [9] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mazzuoli, S.
    Manguso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Minerba, L.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
  • [10] Objectively assessed disease activity during ustekinumab treatment in a nationwide real-life Crohn's disease cohort
    Af Bjorkesten, C. G.
    Ilus, T.
    Hallinen, T.
    Soini, E.
    Eberl, A.
    Hakala, K.
    Heikura, M.
    Hirsi, E.
    Jussila, A.
    Kellokumpu, M.
    Koskela, R.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nieminen, U.
    Nuutinen, H.
    Heikkinen, M.
    Suhonen, U. M.
    Tillonen, J.
    Utriainen, K.
    Vihriala, I.
    Wennerstrom, C.
    Borsi, A.
    Nissinen, R.
    Koivunen, M.
    Sipponen, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S434 - S435
12345